Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3676937
Max Phase: Preclinical
Molecular Formula: C14H16N2O2S
Molecular Weight: 276.36
Molecule Type: Small molecule
Associated Items:
ID: ALA3676937
Max Phase: Preclinical
Molecular Formula: C14H16N2O2S
Molecular Weight: 276.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1CCN(C(=O)Oc2nsc3ccccc23)CC1
Standard InChI: InChI=1S/C14H16N2O2S/c1-10-6-8-16(9-7-10)14(17)18-13-11-4-2-3-5-12(11)19-15-13/h2-5,10H,6-9H2,1H3
Standard InChI Key: XKCVEHZCECADLC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 276.36 | Molecular Weight (Monoisotopic): 276.0932 | AlogP: 3.53 | #Rotatable Bonds: 1 |
Polar Surface Area: 42.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.49 | CX LogD: 3.49 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.80 | Np Likeness Score: -1.42 |
1. (2014) Azole derivatives in the form of lipase and phospholipase inhibitors, |
Source(1):